Abstract: Methods are provided for treating fibrosis of a tissue, including fibrosis of the liver, using combinations of antagomirs and/or locked nucleic acids. Compositions therefor are also provided.
Type:
Application
Filed:
December 6, 2012
Publication date:
June 13, 2013
Applicant:
Albert Einstein College of Medicine of Yeshiva University
Inventor:
Albert Einstein College of Medicine of Yeshiva University
Abstract: Methods and systems are disclosed for assessing a quantitative image volume from an individual subject comprising comparing the image from the subject to images from a control group of subjects using voxel-wise comparison. The methods allow detection of pathologies or lesions in the individual subject being assessed.
Type:
Application
Filed:
February 25, 2013
Publication date:
August 29, 2013
Applicant:
Albert Einstein College of Medicine of Yeshiva University
Inventor:
Albert Einstein College of Medicine of Yeshiva University
Abstract: Methods for reducing peripheral blood glucose levels, food intake, glucose production, gluconeogenesis, triglyceride levels, and low density lipoprotein (VLDL) levels in mammals are provided. Also provided are methods of increasing glucose production and food intake in mammals. Further provided are methods of treating a disorder selected from the group consisting of obesity, type 2 diabetes, type 1 diabetes, hyperglycemia, insulin resistance, glucose intolerance, leptin resistance, metabolic syndrome, heart failure, ischemia, coronary heart disease, familial lipoprotein lipase deficiency, hypopituitarism, hyperlipidemia, hypertriglyceridemia, hyper-VLDLemia, atherosclerosis, hypercholesterolemia, hypertension, and any combination of the foregoing. The methods involve manipulations of amino acid presence or metabolism in the hypothalamus of the mammal.
Type:
Application
Filed:
December 12, 2012
Publication date:
August 15, 2013
Applicant:
Albert Einstein College of Medicine of Yeshiva University
Inventor:
Albert Einstein College of Medicine of Yeshiva University
Abstract: The present invention relates to the purification of proteins, to the products of such purification, and to DNA probes constructed therefrom. More specifically, the invention relates to the purification and sequencing of murine and human colony stimulating factor-1 (CSF-1).
Type:
Grant
Filed:
March 13, 1995
Date of Patent:
August 11, 1998
Assignees:
Chiron Corporation, Albert Einstein College of Medicine
Inventors:
Kenneth J. Wilson, E. Richard Stanley, Albert Boosman, Mary Kim Warren, James E. Strickler, Judit Csejtey
Abstract: The interior surface of a container, such as a bloodbag, is primed and subsequently coated with a time-releasable viricide against HIV absorbed in a hydrogel polymer. The viricides of this invention are derivatives of urea, and upon release into the blood, have no adverse effects on the red blood cell functions of the blood.
Type:
Grant
Filed:
November 19, 1991
Date of Patent:
April 5, 1994
Assignees:
Hydro Slip Technologies Inc., Albert Einstein College of Medicine
Inventors:
Arye Rubinstein, Albert Goldstein, Howard I. Podell
Abstract: The present invention provides a method for identifying a tumor as likely to metastasize, or likely to have metastasized, comprising obtaining a sample of the tumor and quantitating alternatively spliced mRNA isoforms of a cell motility gene, a cell adhesion gene and/or an actin cytoskeletal remodeling gene in the sample, or any specified genes or the level of RNA binding proteins compared to a predetermined non-metastasizing control.
Type:
Application
Filed:
February 24, 2012
Publication date:
March 6, 2014
Applicants:
Massachusetts Institute of Technology, Montefiore Medical Center, Albert Einstein College of Medicine of Yeshiva University
Inventors:
Frank B. Gertler, Christopher Boyce Burge, Irina M. Shapiro, Wu Albert Cheng, John S. Condeelis, Maja H. Oktay
Abstract: The present invention provides a method for identifying a tumor as likely to metastasize, or likely to have metastasized, comprising obtaining a sample of the tumor and quantitating alternatively spliced mRNA isoforms of a cell motility gene, a cell adhesion gene and/or an actin cytoskeletal remodeling gene in the sample, or any specified genes or the level of RNA binding proteins compared to a predetermined non-metastasizing control.
Type:
Grant
Filed:
February 24, 2012
Date of Patent:
March 27, 2018
Assignees:
Massachusetts Institute of Technology, Montefiore Medical Center, Albert Einstein College of Medicine, Inc.
Inventors:
Frank B. Gertler, Christopher Boyce Burge, Irina M. Shapiro, Wu Albert Cheng, John S. Condeelis, Maja H. Oktay
Abstract: Provided are anti-human Tim-3 IgV domain-specific antibodies and fragments thereof, as well as methods of use employing such antibodies and/or fragments.
Abstract: Disclosed are methods and compositions for treating pulmonary arterial hypertension and/or obesity using inhibitors of prostaglandin transporter (PGT) activity.
Type:
Application
Filed:
June 17, 2014
Publication date:
April 28, 2016
Applicant:
Albert Einstein College of Medicine, Inc.